AGT says gene therapy is a ‘potential cure’ for HIV
American Gene Technologies (AGT) calls its gene therapy, AGT103-T, a “potential cure” for ...
Read More
Novavax announces phase 2 trial for combined COVID/flu vaccine
Novavax, a biotech company dedicated to developing and commercializing next-generation vaccines for serious ...
Read More
Biotech might beat inflation, offer hope for investors
With an alarming global inflation rate and businesses generating lower revenues, the economic ...
Read More
2-million-year-old DNA could show solutions to future climate challenges
Study the past, if you would define the future, Confucius once said. Staying ...
Read More
Vertex partners with Entrada on new approach for muscle dystrophy treatment
Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. have formed a global partnership to ...
Read More
Rolls-Royce introduces new business jet powered by 100% SAF
Rolls-Royce and Gulfstream Aerospace Corp. are conducting the first original equipment manufacturer test ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
July 10, 2025
Read More
LATEST NEWS
BIO's View
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another transformative sector: health care innovation. ...
December 10, 2025
Health
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to attract ...
December 2, 2025
Federal Policy
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research and ...
November 26, 2025
BIO Events
BIO 2025 IP Conference: Challenging times for the laws that drive innovation
Patents offer the intellectual property protections investors need to support biotech innovation. That’s why the Biotechnology Innovation Organization (BIO) annual IP Council and Committees (IPC) ...
November 25, 2025
Latest News
National Family Caregivers Month: Recognizing 63 million Americans
November is National Family Caregivers Month, and to mark the occasion, Bio.News sat down with the National Alliance for Caregiving (NAC) to discuss the crucial ...
November 24, 2025
HEALTH
BIO-CSBA report explains why and how states seek to attract biotech
December 2, 2025
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
November 20, 2025
BIO Coffee Chat: Guiding patients through Part D open enrollment
November 17, 2025
PACE: Downstream effects of IRA on patients
November 11, 2025
PACE panel urges incentives for exciting new GTT drugs
November 10, 2025
PACE: How 340B outgrew its goal and stopped helping patients
November 4, 2025
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
November 20, 2025
BIO Coffee Chat: Guiding patients through Part D open enrollment
November 17, 2025
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
December 10, 2025
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
BIO-CSBA report explains why and how states seek to attract biotech
December 2, 2025
BIO brings together patient advocates and industry at PACE
October 27, 2025
September Coffee Chat: The State of Patient Access
October 23, 2025
International
BIO 2025: The world can’t wait – it needs to collaborate
June 23, 2025
BIO IP expert reviews the current policy landscape
April 26, 2025
BIO’s mission to Tokyo builds on fruitful cooperation
March 25, 2025
USMCA dispute panel halts Mexico’s ban on biotech corn
January 6, 2025
Bio's View
Charlotte emerging as a global leader in health care innovation and med tech
December 10, 2025
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
November 20, 2025
Putting Americans First: International prices in context
September 15, 2025


















